Mercado mundial de cultivos celulares automatizados: tendencias de la industria y pronóstico hasta 2031

Análisis y perspectivas del mercado de cultivos celulares automatizados

El mercado de cultivos celulares automatizados está experimentando un sólido crecimiento impulsado por los avances en biotecnología, investigación farmacéutica y fabricación biofarmacéutica. Estos sistemas automatizados desempeñan un papel crucial en la mejora de la productividad, la eficiencia y la reproducibilidad en los procesos de cultivo celular. Los factores clave que impulsan la expansión del mercado incluyen la creciente demanda de cribado de alto rendimiento en el descubrimiento de fármacos, un mayor enfoque en la medicina personalizada y la necesidad de procesos de bioproducción eficientes. Los sistemas automatizados de cultivo celular automatizan tareas como la reposición de medios, el monitoreo de células y el análisis de datos, lo que reduce los costos laborales y minimiza el error humano. Además, los avances tecnológicos como la integración con algoritmos de inteligencia artificial (IA) y aprendizaje automático (ML) están optimizando aún más las condiciones de cultivo celular y mejorando los resultados experimentales.

El tamaño del mercado global de cultivos celulares automatizados se valoró en USD 12,98 mil millones en 2023 y se proyecta que alcance los USD 25,67 mil millones para 2031, con una CAGR del 8,9% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado       

Definición de mercado

Los cultivos celulares automatizados se refieren a sistemas y tecnologías que automatizan los procesos involucrados en el crecimiento y mantenimiento de cultivos celulares en entornos de laboratorio. Estos sistemas generalmente implican plataformas automatizadas que controlan las condiciones ambientales, como la temperatura, la humedad y los niveles de CO2, así como el manejo automatizado de los recipientes de cultivo celular, los cambios de medios y el monitoreo del crecimiento y la viabilidad celular.             

Dinámica del mercado de cultivos celulares automatizados

Conductores

• Demanda creciente de productos biofarmacéuticos        

La creciente producción de productos biofarmacéuticos, incluidos los anticuerpos monoclonales y las vacunas , requiere sistemas de cultivo celular robustos y escalables. Las tecnologías de cultivo celular automatizadas son fundamentales para agilizar el proceso de fabricación, garantizar una mayor calidad del producto y minimizar los riesgos de contaminación. Estos sistemas mejoran la eficiencia y la reproducibilidad de la producción biofarmacéutica, lo que los hace indispensables en la industria. A medida que la demanda de productos biofarmacéuticos sigue creciendo, impulsada por su eficacia y especificidad en el tratamiento de diversas enfermedades, se espera que el mercado de los sistemas de cultivo celular automatizados se expanda significativamente.               

• Crecientes inversiones en investigación en ciencias de la vida            

Substantial investments in life sciences research by governments, academic institutions, and private companies are driving the demand for advanced cell culture systems. Automated cell culture technologies are critical in enabling high-throughput screening and more efficient research workflows. These systems support a wide range of scientific discoveries by providing reliable and consistent cell cultures, which are essential for various research applications, including drug discovery and development. The continuous influx of funding into life sciences research underscores the importance of automated cell culture systems in advancing scientific knowledge and innovation.

Opportunities

• Expansion of Biotechnology and Pharmaceutical Industries   

The rapid growth of the biotechnology and pharmaceutical industries, fueled by the development of new drugs and therapies, is significantly increasing the need for automated cell culture systems. These industries rely on advanced cell culture technologies for various stages of drug discovery, development, and production. Automated systems offer the precision, scalability, and efficiency required to meet the high demands of these processes. As biotechnology and pharmaceutical companies continue to expand and innovate, the adoption of automated cell culture systems is expected to rise, creating opportunities for market growth.              

• Technological Advancements in Cell Culture Systems   

Continuous innovations in automated cell culture technologies, including the integration of artificial intelligence (AI) and machine learning, are revolutionizing the field. These advancements enhance the efficiency, accuracy, and scalability of cell culture processes, making them more accessible and effective for various applications. AI and machine learning algorithms optimize cell growth conditions, predict potential issues, and streamline operations, leading to more consistent and reliable outcomes. The ongoing technological advancements are driving the widespread adoption of automated cell culture systems in both research and industrial settings, contributing to market expansion.

Restraints/Challenges

• High Initial Costs for Cell Culture Systems   

The significant capital investment required for acquiring and installing automated cell culture systems poses a major barrier, particularly for smaller laboratories and research institutions. The high costs associated with purchasing the equipment, as well as the expenses related to maintenance and training, can limit market adoption. Smaller entities may struggle to justify the upfront costs despite the long-term benefits, potentially slowing down the widespread implementation of these advanced systems, and creating challenges for the market.    

• Technical Complexity of Cell Culture Systems        

The complexity of automated cell culture systems, including the need for specialized skills and expertise for their operation and maintenance, can hinder their widespread adoption. Laboratories may face significant challenges in integrating these sophisticated systems into their existing workflows. The technical demands require substantial training and adaptation, which can be daunting for some users. Overcoming these technical hurdles through user-friendly designs and comprehensive training programs is essential to facilitate broader acceptance and utilization of automated cell culture technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, SINFONIA TECHNOLOGY CO., LTD. announced the delivery of two units of its CellQualia Intelligent Cell Processing (ICP) System to Keio University. These systems were delivered in March and completed their Performance Qualification in April of the same year. The devices are set to support the stable production and supply of high-quality cell medicines, crucial for advancing regenerative medicine, a promising next-generation medical treatment
• In October 2023, Molecular Devices, LLC., a prominent provider of high-performance solutions in life sciences and an operating entity within Danaher Corporation's (NYSE: DHR) life sciences segment, introduced the patent-pending CellXpress.ai Automated Cell Culture System. This innovative solution integrates an incubator, liquid handler, and imager, enhanced with machine-learning capabilities

Automated Cell Cultures Market Scope

The market is segmented on the basis of products, type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Product

• Consumables
• Instruments

 Type

• Infinite Cell Line Cultures
• Finite Cell Line Cultures

 Application

• Drug Development
• Stem Cell Research
• Regenerative Medicine
• Cancer Research
• Vaccines
• Other

End User

• Biotech Companies
• Research Organizations
• Academic Research Institutes
• Other

Automated Cell Cultures Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, source, products, type, application, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to substantial investments in life sciences. This region benefits from a robust infrastructure for research and development, with significant funding directed towards lab consumables and advanced technologies. Pharmaceutical and biotechnological industries in North America are heavily investing in automated cell culture systems to enhance their research capabilities and streamline production processes.        

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing productivity and investments in life sciences. Countries in this region, such as China, India, and Japan, are making significant strides in biotechnology and pharmaceutical research. Government initiatives and favorable policies aimed at boosting healthcare infrastructure and research capabilities are contributing to the market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Automated Cell Cultures Market Share Analysis

El panorama competitivo del mercado proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Algunos de los principales actores que operan en el mercado son:

• Sartorius AG (Alemania)
• Danaher (Estados Unidos)
• Lonza (Suiza)
• Nexcelom Bioscience LLC (Estados Unidos)
• Laboratorios HiMedia (India)
• Cell Culture Company, LLC (Estados Unidos)
• Instrumentos avanzados (EE. UU.)
• CORPORACIÓN SHIBUYA (Japón)
• NanoEntek (Corea del Sur)
• FUJIFILM Holdings America Corporation (Estados Unidos)
• Hitachi, Ltd. (Estados Unidos)
• Kawasaki Heavy Industries, Ltd. (Japón)
• Sphere Fluidics Limited (Reino Unido)
• Thrive Bioscience (Estados Unidos)
• Eppendorf AG (Alemania)
• CellGenix GmbH (Alemania)
• ChemoMetec (Dinamarca)
• PromoCell GmbH (Alemania)
• Thermo Fisher Scientific (Estados Unidos)
• BioSpherix, Ltd. (Estados Unidos)
• Merck KGaA (Alemania)
• Tecan Trading AG (Suiza)
• Compañía Hamilton (Estados Unidos)
• BD (Estados Unidos)
• Benchmark Scientific, Inc. (Estados Unidos)
• Atención sanitaria Biotron (India)
• RWD Life Science Co., LTD (Estados Unidos)
• Corning Incorporated (Estados Unidos)
• Bulldog-Bio (Estados Unidos)
• Sphere Fluidics Limited (Reino Unido)

SKU-13174